← FDA DRUG APPROVALS

FDA ANDA · ANDA078720

AMANTADINE HCL

amantadine hydrochloride

Sponsor: BIONPHARMA

APPLICATION
ANDA078720
TYPE
ANDA
ORIGINAL APPROVAL
2008-05-29
LATEST ACTION
2025-07-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

AMANTADINE HYDROCHLORIDEPrescription
AMANTADINE HYDROCHLORIDE 100MG · CAPSULE · ORAL

Approval history

2025-07-10Labeling · Supplement 24 · standardAP
2017-10-30Manufacturing (CMC) · Supplement 13AP
2011-08-01Labeling · Supplement 8AP
2009-03-25Labeling · Supplement 1AP
2008-05-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →